PMS Registry
Company Name
Bayer Taiwan Co., Ltd.
Protocol Number
18728
Title of Study
Xarelto Evidence in Real Life of Patients Preference and Satisfaction Study (X-PRESS)
Primary Objective
The main objective of the study is to assess preferences of Non Valvular Atrial Fibrillation (NVAF) patients towards different options of an anticoagulation treatment.
Number of Sites
10
Period of Study
From:08/09/2016 to:08/31/2017
Number of Patients
300人
IRB Approval Date
CGH:08/10/2016
CMUH:06/07/2016
CGMH:07/18/2016
CSH:07/26/2016
TSGH:07/19/2016
TC VGH、SKH、CHGH、KMUH、MMH: In approval process
Publication Plan / Date
TBD